Application of Instrumental Variables Method in Pharmacoepidemiology: An Example of Beta2-Agonist Use and Myocardial Infarction

被引：0
|
作者：
Uddin, M. Jamal [1 ]
Groenwold, Rolf H. H. [1 ,2 ]
de Boer, Anthonius [1 ]
Belitser, Svetlana V. [1 ]
Hoes, Arno W. [2 ]
Roes, Kit C. B. [2 ]
Klungel, Olaf H. [1 ,2 ]
机构：
[1] Univ Utrecht, Utrecht, Netherlands
[2] Univ Med Ctr Utrecht, Julius Ctr Hlth Sci & Primary Care, Utrecht, Netherlands
来源：
PHARMACOEPIDEMIOLOGY AND DRUG SAFETY | 2013年 / 22卷
关键词：
D O I：
暂无
中图分类号：
R1 [预防医学、卫生学];
学科分类号：
1004 ; 120402 ;
摘要：
61
引用
收藏
页码：32 / 33
页数：2
相关论文
共 29 条
  • [21] Disease Burden Associated with Real-World Patterns of Short-Acting Beta2-Agonist and Systemic Corticosteroid Use Among Patients with Mild Asthma
    Lugogo, N.
    Gilbert, I. A.
    Goshi, N.
    Gandhi, H. N.
    Surmont, F.
    Moore-Schiltz, L.
    Tkacz, J.
    Lanz, M.
    [J]. AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2020, 201
  • [22] Evidence for no association between use of beta-2-agonists and risk of acute myocardial infarction in patients with hypertension
    de Vries, Frank
    Pouwels, Sander
    Bracke, Madelon
    Klungel, Olaf
    Lammers, Jan-Willem
    Leufkens, Hubert
    van Staa, Tjeerd
    [J]. PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, 2007, 16 : S40 - S40
  • [23] Associations Between Asthma Control, Adherence and Short-Acting Beta2-Agonist (SABA) Use in Patients With Uncontrolled Asthma Using a Maintenance and Reliever Digital System (MRDS)
    Mosnaim, G.
    Hoyte, F.
    Safioti, G.
    Magnus, N.
    Brown, R.
    Hill, T.
    Sagalovich, K.
    Wechsler, M. E.
    [J]. AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2023, 207
  • [24] Asthma Disease Burden in US Children Aged 4-11 Years as Revealed by Real-World Patterns of Short-Acting Beta2-Agonist and Systemic Corticosteroid Use
    Lanz, M. J.
    Gilbert, I.
    Goshi, N.
    Gandhi, H.
    Surmont, F.
    Moore-Schiltz, L.
    Tkacz, J.
    Lugogo, N.
    [J]. AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2020, 201
  • [25] USE OF A COLUMN CHROMATOGRAPHIC METHOD FOR MEASUREMENT OF LACTATE-DEHYDROGENASE ISOENZYMES 1 AND 2 IN DIAGNOSIS OF ACUTE MYOCARDIAL-INFARCTION
    MERCER, DW
    VASUDEVAN, G
    VARAT, MA
    [J]. CLINICAL CHEMISTRY, 1977, 23 (06) : 1142 - 1142
  • [26] USE OF A COLUMN-CHROMATOGRAPHIC METHOD FOR THE DETERMINATION OF CREATIN-KINASE-ISOENZYME (CK-2) IN PATIENTS WITH MYOCARDIAL-INFARCTION - THE INTERESTING CLINICAL PICTURE
    BENDER, V
    MROCHEN, H
    DAUBERSCHMIDT, R
    MEYER, M
    KAHL, PE
    BIENERT, I
    ZERBES, M
    TITTMANN, F
    [J]. DEUTSCHE GESUNDHEITSWESEN-ZEITSCHRIFT FUR KLINISCHE MEDIZIN, 1980, 35 (33): : 1309 - 1313
  • [27] Association of glucagon-like peptide-1 receptor agonist use and rates of acute myocardial infarction, stroke and overall mortality in patients with type 2 diabetes mellitus in a large integrated health system
    Zimmerman, Robert S.
    Hobbs, Todd M.
    Wells, Brian J.
    Kong, Sheldon X.
    Kattan, Michael W.
    Bouchard, Jon
    Chagin, Kevin M.
    Yu, Changhong
    Sakurada, Brian
    Milinovich, Alex
    Weng, Wayne
    Bauman, Janine M.
    Pantalone, Kevin M.
    [J]. DIABETES OBESITY & METABOLISM, 2017, 19 (11): : 1555 - 1561
  • [28] APPARENT SUPERIORITY OF H-2-RECEPTOR STIMULATION AND SIMULTANEOUS BETA-BLOCKADE OVER CONVENTIONAL TREATMENT WITH BETA-SYMPATHOMIMETIC DRUGS IN POST-ACUTE MYOCARDIAL-INFARCTION - CARDIAC EFFECTS OF IMPROMIDINE - A NEW SPECIFIC H-2-RECEPTOR AGONIST - IN THE SURVIVING CATECHOLAMINE-INSENSITIVE MYOCARDIUMIC
    BAUMANN, G
    FELIX, SB
    HEIDECKE, CD
    RIESS, G
    LOHER, U
    LUDWIG, L
    BLOMER, H
    [J]. AGENTS AND ACTIONS, 1984, 15 (3-4): : 216 - 228
  • [29] New cardiology aspects of triple antithrombotic therapy, diabetes without insulin therapy as a risk factor in atrial fibrillation, treatment of gout, cholesterol lowering treatment, prostate cancer treatment, out-of-hospital cardiac arrest, Fabry disease, beta-blocker use after myocardial infarction in patients with normal ejection fraction, cardio-renal benefits of SGLT2 Inhibitors and interpretation of clinical trials
    Agewall, Stefan
    [J]. EUROPEAN HEART JOURNAL-CARDIOVASCULAR PHARMACOTHERAPY, 2022, 8 (03) : 213 - 215
123